Skip to main navigation Skip to search Skip to main content

Erratum: Maintenance of clinical remission in early axial spondyloarthritis following certolizumab pegol dose reduction (Arthritis Rheum (2005) 53: 5 (703 709) DOI: 10.1002/art.21445)

Research output: Contribution to journalErratum/CorrigendumAcademic

Abstract

Landewe RB, van der Heijde D, Dougados M, et al. Maintenance of clinical remission in early axial spondyloarthritis following certolizumab pegol dose reduction. Ann of Rheum Dis 2020;79:920 8 A citation to the following paper should be included after first mention of the copyrighted SPARCC instrument: Maksymowych WP, et al. Spondyloarthritis Research Consortium of Canada magnetic resonance imaging index for assessment of sacroiliac joint inflammation in ankylosing spondylitis. Arthritis Rheum 2005;53(5):703 9. doi: 10.1002/art.21445.
Original languageEnglish
Article number216839
JournalAnnals of the rheumatic diseases
Volume79
Issue number9
DOIs
Publication statusPublished - 1 Sept 2020

Fingerprint

Dive into the research topics of 'Erratum: Maintenance of clinical remission in early axial spondyloarthritis following certolizumab pegol dose reduction (Arthritis Rheum (2005) 53: 5 (703 709) DOI: 10.1002/art.21445)'. Together they form a unique fingerprint.

Cite this